URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 30.0% of their position (13.68K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $726.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2026ACC: 0001838139-26-000016
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-13.68K
Net shares
Net seller
$726.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.68K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
−13.68K
Price / share
$53.06
Trade value
$726.14K
% of position
30.0%
5/14/2026
45.56K→31.88K
Total
Net shares
−13.68K
Net value
-$726.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 5/14/2026 | S · Sale | −13.68K | $53.06 | $726.14K | 30.0% | 45.56K | 31.88K |
| Total | −13.68K | -$726.14K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported